News
13h
Zacks Investment Research on MSNDanaher Partners With AstraZeneca to Support Precision MedicineDanaher Corporation DHR recently partnered with AstraZeneca PLC AZN to develop and market novel diagnostic tools aimed at ...
AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises ...
AstraZeneca AZN0.60%increase; green up pointing triangle plans to spend GBP650 million ($828.8 million) on vaccine programs and various other initiatives in the U.K. The pharmaceutical company ...
AstraZeneca succeeded in thwarting Pfizer's takeover plans – but was forced to promise investors that it could deliver very rapid growth – forecasting revenues of $45 billion by 2023, compared ...
A few weeks later, Donelan was invited to visit AstraZeneca’s research and development site in Cambridge, the heartland of Britain’s life sciences sector, where she was treated to a glitzy ...
The new Global R&D Centre will become the focal point for oncology research within AstraZeneca worldwide. Your forte could be the lab or Biometrics, Projects or Regulatory. Join us in Cambridge or ...
But private sector companies like AstraZeneca are pushing forward with major investments in life sciences research and manufacturing. The Cambridge, U.K.-based pharmaceutical giant on Monday ...
CAMBRIDGE, England, November 12, 2024--(BUSINESS WIRE)--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and ...
CAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion. On a per-share basis, the Cambridge, Britain-based company ...
The new functional genomics lab is the result of a partnership between Cambridge, AstraZeneca, and the U.K.’s Medical Research Council, and is part of the U.K.’s Human Functional Genomics ...
The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million in 2024. The chief executive of drugmaker AstraZeneca was handed a pa ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results